Cargando…
Immunoprofile from tissue microarrays to stratify familial breast cancer patients
Familial breast cancer (BC) is a heterogeneous disease with variable prognosis. The identification of an immunoprofile is important to predict tumor behavior for the routine clinical management of familial BC patients. Using immunohistochemistry on tissue microarrays, we studied 95 familial BCs in o...
Autores principales: | Schirosi, Laura, De Summa, Simona, Tommasi, Stefania, Paradiso, Angelo, Sambiasi, Domenico, Popescu, Ondina, Simone, Giovanni, Mangia, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695031/ https://www.ncbi.nlm.nih.gov/pubmed/26312763 |
Ejemplares similares
-
Comment on ‘Renewed interest in the progesterone receptor in breast cancer’
por: Simone, Giovanni, et al.
Publicado: (2017) -
Adipokines in hereditary breast cancer patients and healthy relatives
por: Sambiasi, Domenico, et al.
Publicado: (2017) -
Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients
por: Danza, Katia, et al.
Publicado: (2014) -
Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
por: Schirosi, Laura, et al.
Publicado: (2016) -
Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients
por: Schirosi, Laura, et al.
Publicado: (2019)